We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Gene Therapy Technique Cures Cystic Fibrosis in Culture Model

By LabMedica International staff writers
Posted on 31 Jul 2009
Print article
A gene therapy technique based on a parainfluenza virus vector was used to successfully cure an in vitro model of cystic fibrosis.

Cystic fibrosis (CF) lung disease results from reduced airway surface hydration leading to decreased mucus clearance that precipitates bacterial infection and progressive obstructive lung disease. CF is a genetic disease, and the mutant protein is a chloride ion channel (CFTR) that normally regulates ion and fluid transport on the airway surface.

Investigators at the University of North Carolina (Chapel Hill, USA) reasoned that the most appropriate means for delivering a gene to lung tissue was a virus that specialized in invading the lungs. They created an in vitro model of CF by growing cultures of ciliated surface airway epithelium (CF HAE) cells obtained from a CF patient. The cultures were then treated with parainfluenza virus that had been genetically engineered to carry the normal CFTR gene.

Results published in the July 21, 2009, online edition of the journal PLoS Biology revealed that the vector delivered CFTR to more than 60% of airway surface epithelial cells, and the expression of CFTR protein in the CF HAE cells was approximately 100-fold higher than endogenous levels found in normal HAE cells.

By titering the amount of CFTR gene in the vector, the investigators were able to determine that uptake of the gene by 25% of the cells was sufficient to restore normal function to the entire culture.

"We discovered that if you take a virus that has evolved to infect the human airways, and you engineer a normal CFTR gene into it, you can use this virus to correct all of the hallmark CF features in the model system that we used,” said senior author Dr. Raymond J. Pickles, associate professor of microbiology and immunology at the University of North Carolina. "This is the first demonstration in which we have been able to execute delivery in an efficient manner. When you consider that in past gene therapy studies, the targeting efficiency has been somewhere around 0.1% of cells, you can see this is a giant leap forward.”

"We have not generated a vector that we can go out and give to patients now,” said Dr. Pickles, "but these studies continue to convince us that a gene replacement therapy for CF patients will some day be available in the future.”

Related Links:
University of North Carolina


Gold Member
Turnkey Packaging Solution
HLX
Automated Blood Typing System
IH-500 NEXT
New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
New
Food Allergens Assay Kit
Allerquant 14G A

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The AI program analyzes a microscopy image from a tumor biopsy and determines what genes are likely turned on and off in the cells it contains (Photo courtesy of Olivier Gevaert/Stanford Medicine)

AI Tool ‘Sees’ Cancer Gene Signatures in Biopsy Images

To assess the type and severity of cancer, pathologists typically examine thin slices of a tumor biopsy under a microscope. However, to understand the genomic alterations driving the tumor's growth, scientists... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.